Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.2 was added and the v3.4.1 notice was removed. This appears to be a site maintenance update that does not affect the clinical trial details on the page.SummaryDifference0.5%

- Check11 days agoChange DetectedSite-wide notices were added about government funding lapse and clinic operations, and the site revision was updated to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check18 days agoChange DetectedShow glossary option added and metadata labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check32 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, indicating a version update of the page. No study details or user-facing functionality are altered.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.3.3 is now displayed; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision history updated to add v3.3.2 and remove v3.3.1. These are administrative metadata changes that do not modify study content.SummaryDifference0.1%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.